FA
AMED

FDx Advisors’s Amedisys AMED Stock Holding History

FDx Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,863
Closed -$536K – 629
2023
Q2 		$536K Buy
5,863
+3,102
+112% +$254K 0.03% 433
2023
Q1 		$231K Hold
2,761
– – 0.01% 659
2022
Q4 		$231K Sell
2,761
-360
-12% -$32.5K 0.01% 659
2022
Q3 		$302K Sell
3,121
-4,646
-60% -$554K 0.01% 552
2022
Q2 		$816K Buy
+7,767
New +$992K 0.03% 358
2022
Q1 		– Sell
-3,609
Closed -$584K – 826
2021
Q4 		$584K Sell
3,609
-2,603
-42% -$418K 0.02% 490
2021
Q3 		$926K Buy
6,212
+361
+6% +$75K 0.03% 356
2021
Q2 		$1.43M Buy
5,851
+996
+21% +$261K 0.05% 257
2021
Q1 		$1.29M Buy
4,855
+1,405
+41% +$396K 0.05% 242
2020
Q4 		$1.01M Buy
3,450
+602
+21% +$154K 0.04% 264
2020
Q3 		$673K Buy
+2,848
New +$648K 0.03% 310
2019
Q3 		– Sell
-5,345
Closed -$649K – 629
2019
Q2 		$649K Buy
+5,345
New +$634K 0.03% 426

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FDx Advisors's AMED Position: Q3 2023 in Review

FDx Advisors sold out of Amedisys (AMED) in Q3 2023, closing a stake of 5,863 shares — an estimated $536K sold.

FDx Advisors first reported a position in AMED in Q2 2019 and held it in 12 quarters. The position peaked at $1.43M in Q2 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • FDx Advisors reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • FDx Advisors sold 5,863 Amedisys shares in Q3 2023, an estimated $536K.
  • FDx Advisors first reported a position in Amedisys in Q2 2019 and held it in 12 quarters.
  • FDx Advisors's Amedisys position peaked at $1.43M in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on FDx Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.